<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20151107024919N23</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-10-10</date_registration>
      <primary_sponsor>Kerman University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of Mindfulness on Body Shame and Self-Stigma in patients with type 1 Diabetes referred to the Healthcare Centers of Kerman University of Medical Sciences</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Mindfulness on Body Shame and Self-Stigma in patients with type 1 Diabetes referred to the Healthcare Centers of Kerman University of Medical Sciences</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/93514</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: In this study, the researcher will visit the healthcare centers of Kerman University of Medical Sciences to recruit eligible individuals. Eligible patients will be selected via convenience sampling. To allocate participants to the control and intervention groups, stratified randomization based on gender will be employed. Participants will first be stratified by gender (male and female), and then within each stratum, they will be randomly assigned to either the control or intervention group using a simple randomization method with a 1:1 allocation ratio. The randomization sequence will be generated using Open Epi software. To ensure allocation concealment, the randomization list will be held by an individual independent of the research team. Allocation for each participant will be assigned by contacting this person, ensuring that the researcher remains blinded to the group assignment until the patient is officially enrolled in the study, Blinding description: Due to the educational nature of the intervention, blinding of participants and the researcher is not feasible. However, since the scoring is self-reported by the patients, the potential for researcher bias in the results is minimized. Furthermore, to control for bias during the data analysis phase, the data will be analyzed by an independent statistician who is blinded to group assignments. Data for both the intervention and control groups will be entered into SPSS and labeled as ‘Group 1’ and ‘Group 2.’ The analyst will remain unaware of which group corresponds to the intervention and which to the control throughout the analysis process.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: type 1 Diabetes. Condition 2: Psychological factors associated with Type 1 diabetes.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention is based on a modified version of the Mindfulness-Based Stress Reduction (MBSR) program originally developed by Kabat-Zinn. It consists of eight weekly group sessions, each lasting approximately 90 to 120 minutes. The sessions incorporate various mindfulness practices, including sitting meditation, body scan, walking meditation, and mindful movement, alongside discussions on concepts related to present-moment awareness and mindful responding to stress. The researcher has completed the MBSR training under the supervision of the thesis advisor, who will verify the competence and adequacy of the instruction. Homework and exercises will be assigned at the end of each session for practice between meetings. Additionally, educational videos and supplementary explanations will be provided asynchronously via the ‘Eitaa’ messenger, which will also serve as a platform for participants to ask questions, receive answers, and resolve issues. The researcher will monitor the completion of practice assignments and provide necessary feedback. Each session will commence with a review of participants’ experiences with the previous week’s exercises, offering sufficient opportunity for Q&amp;A, troubleshooting, feedback, and discussion regarding barriers to practice. Intervention 2: Control group: Participants in the control group will not receive any educational content. Interaction with this group will be limited to necessary notifications regarding questionnaire completion schedules and routine clinical follow-ups, including reminders for medical appointments and the opportunity to ask general questions related to diabetes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is The researcher is ethically reluctant to share.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Batool Tirgari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kerman University of Medical Sciences, Medical University Campus, Haft-Bagh-Alavi Highway, Kerman</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913555</zip>
        <telephone>+98 34 3132 5207</telephone>
        <email>b_tirgari@kmu.ac.ir</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Batool Tirgari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kerman University of Medical Sciences, Medical University Campus, Haft-Bagh-Alavi Highway, Kerman</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913555</zip>
        <telephone>+98 34 3132 5207</telephone>
        <email>b_tirgari@kmu.ac.ir</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Aged 16 to 20
Definitive diagnosis of Type 1 diabetes by an endocrinologist
At least 6 months since the diagnosis of Type 1 diabetes
Ability to read and write and participate in group intervention sessions
Scoring above 17 on the Body Image Shame Scale
Scoring above 21 on the Diabetes Self-Stigma Scale</inclusion_criteria>
      <agemin>16 years</agemin>
      <agemax>20 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Diagnosis of severe psychiatric disorders such as psychosis, autism, developmental delay, or suicidal ideation
Presence of comorbid physical or chronic conditions (excluding hypertension) that interfere with diabetes management, such as cystic fibrosis, or renal and liver diseases
History of substance abuse</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E10</hc_code>
      <hc_code>F54</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Type 1 diabetes mellitus</hc_keyword>
      <hc_keyword>Psychological and behavioral factors associated with disorders or diseases classified elsewhere</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention is based on a modified version of the Mindfulness-Based Stress Reduction (MBSR) program originally developed by Kabat-Zinn. It consists of eight weekly group sessions, each lasting approximately 90 to 120 minutes. The sessions incorporate various mindfulness practices, including sitting meditation, body scan, walking meditation, and mindful movement, alongside discussions on concepts related to present-moment awareness and mindful responding to stress. The researcher has completed the MBSR training under the supervision of the thesis advisor, who will verify the competence and adequacy of the instruction. Homework and exercises will be assigned at the end of each session for practice between meetings. Additionally, educational videos and supplementary explanations will be provided asynchronously via the ‘Eitaa’ messenger, which will also serve as a platform for participants to ask questions, receive answers, and resolve issues. The researcher will monitor the completion of practice assignments and provide necessary feedback. Each session will commence with a review of participants’ experiences with the previous week’s exercises, offering sufficient opportunity for Q&amp;A, troubleshooting, feedback, and discussion regarding barriers to practice.</i_keyword>
      <i_keyword>Control group: Participants in the control group will not receive any educational content. Interaction with this group will be limited to necessary notifications regarding questionnaire completion schedules and routine clinical follow-ups, including reminders for medical appointments and the opportunity to ask general questions related to diabetes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Body Shameا. Timepoint: The effect of a mindfulness-based training program on body shame in patients with Type 1 diabetes is evaluated in two stages: pre-intervention and immediately post-intervention (at the end of week 8). Method of measurement: BISS: Body Image Shame Scale.</prim_outcome>
      <prim_outcome>Self-Stigma. Timepoint: The effect of a mindfulness-based training program on self-stigma in patients with Type 1 diabetes is evaluated in two stages: pre-intervention and immediately post-intervention (at the end of the 8th week). Method of measurement: DSSS: Diabetes Self-Stigma Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kerman University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-09-12</approval_date>
        <contact_name>Ethics Committee of Kerman University of Medical Sciences</contact_name>
        <contact_address>Kerman University of Medical Sciences, Medical University Campus, Haft-Bagh Highway, Kerman, Iran Kerman Kerman Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
